Ikarian Capital »

Annexon shares owned by Ikarian Capital

Quarter-by-quarter ownership of Annexon (ANNX) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Annexon

Tip: Access up to 7 years of quarterly data

All positions including Annexon held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Annexon by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $12M 2.7M 4.54

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Annexon

Satter Management
BVF
Redmile Group
Logos Global Management
GMT Capital Corp
Ikarian Capital
Octagon Capital Advisors
Vanguard Group
Kennedy Capital Management
Citadel Advisors
Millennium Management
Massachusetts Financial Services
Vontobel Holding
Deerfield Management Company
Soleus Capital Management

View all funds holding Annexon